Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Zynerba Pharmaceuticals
Biotech
Zynerba soars on Fragile X data
Zynerba’s stock doubled on news of the route to redemption, despite the study’s lack of a control arm leaving reason to question the drug's effect.
Nick Paul Taylor
Sep 28, 2017 10:03am
Zynerba repeat failure, Peregrine clipped and more—News of Note
Aug 14, 2017 9:39am
Zynerba sinks after total failure in phase 2 cannabidiol trial
Aug 7, 2017 10:26am